Gincosan

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Panax ginseng, Quantity: 100 mg (Equivalent: Panax ginseng, Qty 212.5 mg; Equivalent: ginsenosides Rg1- Re- Rf- Rg2- Rb1- Rb2- Rc- Rd (of Panax ginseng), Qty 4 mg); Ginkgo biloba, Quantity: 60 mg (Equivalent: Ginkgo biloba, Qty 2.16 g; Equivalent: Ginkgo flavonglycosides, Qty 14.7 mg; Equivalent: Ginkgolides and bilobalide, Qty 3.6 mg)

Disponible des:

SFI Australasia

Designació comuna internacional (DCI):

Ginkgo biloba,Panax ginseng

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: silicon dioxide; magnesium stearate; purified water; mannitol; iron oxide yellow; titanium dioxide; iron oxide red; Gelatin

Vía de administración:

Oral

clase:

Medicine Listed

indicaciones terapéuticas:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support physical endurance/capacity/stamina ; Maintain/support healthy blood circulation ; Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Decrease/reduce mental/cognitive fatigue ; Maintain/support mental concentration/focus/clarity ; Enhance/improve/promote/increase cognitive performance ; Maintain/support cognitive function/mental function ; Maintain/support learning and information processing ; Enhance/improve/promote/increase mental alertness/wakefulness ; Enhance/improve/promote/increase memory/recall ; Maintain/support memory/mental recall ; Enhance/improve/promote/increase short term memory ; Maintain/support brain function

Resumen del producto:

Visual Identification: ;

Estat d'Autorització:

Licence status A

Data d'autorització:

2010-02-13